The rupture of vulnerable atherosclerotic plaques that lead to stroke and myocardial infarction may be induced by macrophage infiltration, and augmented by the expression of integrin α v β 3 Indeed, atherosclerotic angiogenesis may be a promising marker of inflammation. In this study, an engineered integrin α v β 3 integrin targeting positron emission tomography (PET) probe, 64 Cu-NOTA-3-4A, derived from a divalent knottin miniprotein was evaluated in a mouse model for carotid atherosclerotic plaques. Methods: Atherosclerotic plaques in BALB/C mice, maintained on a high fat diet, were induced with streptozotocin injection and carotid artery ligation, and verified by magnetic resonance imaging (MRI). Knottin 3-4A was synthesized by solid phase peptide synthesis chemistry, and coupled to 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA) prior to radiolabeling with 64 Cu. PET probe stability in mouse serum was evaluated.
INTRODUCTION
Cardiovascular disease induced by atherosclerosis is a leading cause of death in the Western world. The majority of myocardial infarctions and sudden cardiac deaths result from the rupture of vulnerable atherosclerotic plaques (1) (2) (3) (4) . Therefore, tools that detect atherosclerotic plaques are needed in the clinic. At present, several imaging modalities are used to identify atherosclerotic lesions in patients, including computed tomography angiography (CTA), magnetic resonance imaging (MRI), intravascular ultrasound (IVUS), etc. Although these imaging modalities have been able to delineate certain features of plaques, their sensitivity and specificity are relatively low (5, 6) . On the other hand, nuclear imaging techniques such as positron emission tomography (PET) may provide a more sensitive and quantitative route to determine the extent of cardiovascular disease (7) .
Inflammation is a well studied feature of atherosclerotic plaques that are at high risk of rupture (1, 2) . Therefore, molecular imaging of inflammation-associated-markers may be a promising tool to quantify rupture risk of plaques, and warn against further adverse cardiovascular events. The most widely studied PET probe for detection of plaque-based inflammation is 18 F-fluorodeoxyglucose ( 18 F-FDG) (8, 9) , which is taken up by active macrophages so that it provides information about the extent of inflammation in atherosclerotic plaques (10) (11) (12) . However, 18 F-FDG is a nonspecific imaging probe for inflammation, because it can also accumulate in clacified structures of vessel walls, muscle tissues adjacent to the vessels as well as tissues with high metabolic rates such as the mycardium and brain. Therefore, new PET probes to image plaque-related inflammation and their propensity to rupture are needed in treating by on . For personal use only. jnm.snmjournals.org Downloaded from 5 heart disease (13) .
Recently, integrin α v β 3 expression in atherosclerosis has been reported to be a promising marker of vulnerable plaques (14) (15) (16) . Integrin α v β 3 receptors are transmembrane glycoproteins, which are highly expressed by not only activated endothelial cells of new vessels in the atherosclerotic plaques, but also activated macrophages that mediate the inflammatory process.
Therefore, radiolabelled peptides such as Arg-Gly-Asparatic acid (RGD) peptide that specifically bind to α v β 3 integrin have been studied by PET imaging of atherosclerotic plaques (13, (17) (18) (19) (20) .
For example, 18 F-Galacto-RGD (13) and 68 Ga-DOTA-RGD (17) have shown specific targeting to integrin α v β 3 . However, their accumulation in atherosclerotic lesions as well as their plaque-to-normal tissue ratios are low in preclinical models. The uptake of 18 F-Galacto-RGD by the aorta plaque was only 0.24%ID/g at 2 h post-injection (p.i.), and the aorta-to-normal vessel wall uptake ratio was 1.3 (13) . The aorta plaque uptake of 68 Ga-DOTA-RGD was 0.90%ID/g at 1 h p.i., and aorta/heart and aorta/blood uptake ratios were 1.8 and 1.1 at 1 h p.i., respectively (17) .
Therefore, PET probes, with higher integrin α v β 3 receptor binding affinity and specificity are needed to be of any clinical utility in management of cardiovascular disease.
Cystine knot peptides, also known as knottins, are small polypeptides that are characterized by a stable core motif formed by multiple disulfide bonds (three or four) that are interwoven into a knotted conformation, which endows these peptides with high thermal and proteolytic stability. physical properties bode well for clinical imaging applications. In our previous studies, monovalent and bivalent integrin α v β 3 knottin binders have been coupled to a variety of multimodal imaging labels (radionuclides and/or fluorescent dyes) and successfully used to image α v β 3 positive tumors in small animal models (21) (22) (23) (24) (25) (26) (27) (28) .
In this work, a bivalent integrin α v β 3 knottin binder 3-4A was conjugated at its N-terminus to 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA) and radiolabeled with 64 Cu for PET imaging.
The resulting probe was successfully used to image integrin α v β 3 expression associated with carotid atherosclerotic plaques.
MATERIALS and METHODS

General and Animal Model
All 9-fluorenylmethyloxycarbonyl (Fmoc) protected amino acids were purchased from Novabiochem/EMD Chemicals Inc. or CS Bio. c(RGDyK) peptide was purchased from Peptides
International. Phosphate buffered saline (PBS, 0.01 M, pH 7.4) was obtained from Gibco/Invitrogen. All other chemicals were purchased from Fisher Scientific unless otherwise specified.
Male BALB/C mice were purchased from Charles River Laboratory. As shown in Figure 1A , carotid atherosclerotic plaques were induced in male BALB/C mice by the following protocol.
Mice (n=20) were fed with a high-fat diet containing 40% kcal fat, of the STZ injections, serum glucose level was measured by sampling tail vein blood and using a glucometer. If the glucose level was below 200 mg/L, animals were injected with additional STZ for 3 consecutive days. At day 14 after initiation of STZ injection, the left common carotid artery was ligated below the bifurcation with the use of 6-0 silk ligature (Ethicon) under 2% inhaled isoflurane. In sham-operated animals, the suture was put around the exposed left carotid artery but not tightened. The wound was closed by suture and the mice were allowed to recover on a warming blanket. All procedures were approved by the Administrative Panel on Laboratory Animal Care at Stanford University.
Small Animal MR Imaging
Mice (n=20) from the treatment described above were sequentially anesthetized using 2% In Vitro Stability 64 Cu-NOTA-3-4A (1.85-3.7 MBq, 50-100 μCi) was incubated in 0.5 mL of mouse serum for 4 h at 37 o C. The mixture was then treated with 0.5 mL of acetonitrile to precipitate the serum protein and centrifuged at 16,000g for 2 min. The supernatant containing greater than 95% of the radioactivity was filtered using a 0.22 μm nylon SpinX column (Corning Inc.). Greater than 99%
of the radioactivity passed through this filter. In addition, 64 Cu-NOTA-3-4A (1.85-3.7 MBq, 50-100 μCi) was also incubated in PBS buffer for 4 h at room temperature. The samples were analyzed by radio-HPLC, and the percentage of intact peptide was determined by quantifying peaks corresponding to the intact peptide and degradation products. 
Small Animal PET/CT
Statistical Analysis
The quantitative data were expressed as mean ± SD. Means were compared using the Student t test. A 95% confidence level was chosen to determine the significance between groups, with P by on August 28, 2017. For personal use only. jnm.snmjournals.org Downloaded from 11 values of less than 0.05 indicating significant differences.
RESULTS
Establishment of Carotid Atherosclerotic Plaques
MRI was used to evaluate whether the carotid atherosclerotic plaques were successfully established in mouse models subjected to PET imaging protocols. Compared to the normal contralateral carotid artery, MRI revealed stenosis within the affected artery as shown on axial MRI image ( Figure 1B ). Moreover, a longitudinal plane of the 3D-FLASH MR images show that blood flow in the affected (left) artery was significantly decreased compared to the normal (right) carotid artery ( Figure 1C ). Following acquisition of MRI and PET data, mouse models were euthanized so that injured artery could be examined by bright field magnification. These anatomic images clearly show the damaged vessel wall (solid white structure) of the left artery ( Figure 1D ). displayed high plaque-to-background tissue (common artery, brain, heart, muscle) ratios ( Figure   4D ). For example, at 1 h after injection, the plaque-to-common artery, plaque-to-brain, plaque-to-heart, plaque-to-muscle ratios of 64 Cu-NOTA-3-4A were 17.47 ± 3.50, 27.76 ± 4.31, 21.31 ± 3.69, and 42.99 ± 5.48, respectively. Moreover, the α v β 3 integrin-targeting specificity of 64 Cu-NOTA-3-4A was evaluated by the co-injection of a large amount of c(RGDyK).
Preparation of
Significantly reduced uptake of 64 Cu-NOTA-3-4A by left carotid atherosclerotic lesion was by on August 28, 2017. For personal use only. jnm.snmjournals.org Downloaded from 13 observed on PET images from 1 h to 24 h p.i. (Figure 4B ).
Comparative 18 F-FDG PET/CT Imaging Study
The atherosclerotic lesion in the left carotid artery was visible at 0. The plaque-to-common artery and plaque-to-muscle ratios of 18 F-FDG at 1 h were 5.56 ± 1.05 and 58.67 ± 3.69, respectively.
Immunofluorescence Staining
To determine whether α v β 3 integrin expression in the carotid atherosclerotic plaques was associated with macrophage infiltration and or angiogenesis, immunohistochemical staining was 
DISCUSSION
In the clinic, 18 F-FDG PET has been used to detect inflammation in vulnerable atherosclerotic plaques and to select patients for vascular surgery (12) . However, lack of specificity hampers clinical utility of 18 F-FDG for cardiovascular disease. Integrin α v β 3 has been reported to be an imaging marker that is highly expressed by both plaque-associated macrophages, and activated endothelial cells, which form plaque neovasculature. Imaging integrin α v β 3 expression could therefore be a usefully noninvasive tool to predict the unstable plaques.
Radiolabeled RGD peptides are of particular interest because they specifically bind integrin
18 F-Galacto-RGD was developed to detect atherosclerotic plaques in the aorta of hypercholesterolemic mice (13) . Although the %ID/g in the aorta was more than 2 times higher than the residual activity in the blood of the same mice, the uptake of 18 F-Galacto-RGD in the aorta was only 0.24 ± 0.07 %ID/g at 2 h p.i., and the aorta-to-normal vessel wall ratio was 1.3.
Further evaluation of 18 F-Galacto-RGD in human carotid plaques revealed a positive correlation between 18 F-Galacto-RGD uptake and α v β 3 expression of carotid plaques (7) . Moreover, 68 Ga-DOTA-RGD was also evaluated in the aorta of hypercholesterolemic mice and showed aorta uptake 0.90 ± 0.21 %ID/g at 1 h p.i., and the aorta/heart and aorta/blood uptake ratios were 1.8 and 1.1 at 1 h p.i., respectively (17) . 18 F-Flotegatide was also reported in a mouse model of aortic plaques. It showed aorta uptake 2.8 ± 0.4 %ID/g at 1 h p.i., and the aorta-to-heart ratio and aorta-to-muscle ratio were 14 and 18, respectively (18) . (32) . Similarly, 64 Cu-NOTA-3-4A may potentially be used to image a variety of integrin α v β 3 positive lesions in human subjects. A variety of engineered cystine-knot peptides coupled to different PET labels are undergoing extensive testing and validation (22, 26, 31) .
Finally, the immunofluorescent staining displayed a correlation between integrin α v β 3 expression and macrophage infiltration, as well as formation of the neovasculature. These data indicate that the uptake mechanism of 64 Cu-NOTA-3-4A by atherosclerotic plaques is through binding to integrin α v β 3 expressed on the surface of macrophages and endothelial cells. Cu-NOTA-3-4A may be a promising PET probe for clinical imaging of carotid atherosclerotic plaques.
CONCLUSION
